- Stocks
- Healthcare
- NASDAQ: CNMD

Price (delayed)

$108.35

Market cap

$3.33B

P/E Ratio

55.85

Dividend/share

$0.8

EPS

$1.94

Enterprise value

$4.31B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,

The stock's price to earnings (P/E) is 88% less than its 5-year quarterly average of 486.0

CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter

The net income has soared by 170% year-on-year but it has declined by 34% since the previous quarter

CNMD's EPS has soared by 169% YoY but it is down by 34% QoQ

CNMD's quick ratio is down by 38% YoY and by 5% QoQ

CNMD's gross margin is down by 3.8% YoY

What are the main financial stats of CNMD

Market
Valuations
Earnings

Shares outstanding

30.75M

Market cap

$3.33B

Enterprise value

$4.31B

Price to earnings (P/E)

55.85

Price to book (P/B)

4.18

Price to sales (P/S)

2.85

EV/EBIT

62.24

EV/EBITDA

50.46

EV/Sales

3.69

Revenue

$1.17B

EBIT

$69.32M

EBITDA

$85.5M

Free cash flow

$37.5M

Per share
Balance sheet
Liquidity

EPS

$1.94

Free cash flow per share

$1.22

Book value per share

$25.9

Revenue per share

$38.01

TBVPS

$27.75

Total assets

$2.33B

Total liabilities

$1.53B

Debt

$1.01B

Equity

$796.21M

Working capital

$249.33M

Debt to equity

1.27

Current ratio

1.66

Quick ratio

0.69

Net debt/EBITDA

11.49

Margins
Efficiency
Dividend

EBITDA margin

7.3%

Gross margin

53.6%

Net margin

5%

Operating margin

5.9%

Return on assets

2.5%

Return on equity

7.5%

Return on invested capital

4.6%

Return on capital employed

3.6%

Return on sales

5.9%

Dividend yield

0.74%

DPS

$0.8

Payout ratio

41.2%

How has the CONMED stock price performed over time

Intraday

-0.09%

1 week

1.97%

1 month

5.68%

1 year

26.25%

YTD

22.24%

QTD

7.44%

How have CONMED's revenue and profit performed over time

Revenue

$1.17B

Gross profit

$625.93M

Operating income

$69.32M

Net income

$57.97M

Gross margin

53.6%

Net margin

5%

The net income has soared by 170% year-on-year but it has declined by 34% since the previous quarter

The company's net margin has surged by 165% YoY but it fell by 36% QoQ

The operating income has increased by 10% since the previous quarter

CNMD's revenue is up by 9% year-on-year and by 2.6% since the previous quarter

What is CONMED's growth rate over time

What is CONMED stock price valuation

P/E

55.85

P/B

4.18

P/S

2.85

EV/EBIT

62.24

EV/EBITDA

50.46

EV/Sales

3.69

CNMD's EPS has soared by 169% YoY but it is down by 34% QoQ

The stock's price to earnings (P/E) is 88% less than its 5-year quarterly average of 486.0

CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter

The stock's price to book (P/B) is 2.6% less than its last 4 quarters average of 4.3 but 2.2% more than its 5-year quarterly average of 4.1

CNMD's revenue is up by 9% year-on-year and by 2.6% since the previous quarter

CNMD's P/S is 8% less than its 5-year quarterly average of 3.1

How efficient is CONMED business performance

The ROE has soared by 167% YoY but it has contracted by 36% from the previous quarter

CNMD's return on assets has surged by 160% year-on-year but it is down by 34% since the previous quarter

CNMD's return on invested capital is up by 12% since the previous quarter

CNMD's ROS is up by 5% QoQ

What is CNMD's dividend history

DPS

$0.8

Dividend yield

0.74%

Payout ratio

41.2%

Recent dividends

How did CONMED financials performed over time

CNMD's total assets is 52% greater than its total liabilities

The current ratio has contracted by 40% YoY and by 4.6% from the previous quarter

CNMD's quick ratio is down by 38% YoY and by 5% QoQ

The company's debt is 27% higher than its equity

The company's debt to equity fell by 12% YoY and by 4.5% QoQ

CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.